Detalhe da pesquisa
1.
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
N Engl J Med
; 388(23): 2159-2170, 2023 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36972022
2.
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Br J Cancer
; 130(5): 861-868, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38195887
3.
A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomes.
Breast Cancer Res Treat
; 206(2): 273-283, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38553649
4.
A whole-food, plant-based randomized controlled trial in metastatic breast cancer: weight, cardiometabolic, and hormonal outcomes.
Breast Cancer Res Treat
; 205(2): 257-266, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38446316
5.
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Gynecol Oncol
; 187: 128-138, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38833992
6.
HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression.
J Immunol
; 206(10): 2478-2488, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903172
7.
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
N Engl J Med
; 381(25): 2391-2402, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562799
8.
HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer.
Tumour Biol
; 44(1): 205-213, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36189508
9.
OVARIO phase II trial of combination niraparib plus bevacizumab maintenance therapy in advanced ovarian cancer following first-line platinum-based chemotherapy with bevacizumab.
Gynecol Oncol
; 166(2): 219-229, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690498
10.
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study.
Gynecol Oncol
; 166(1): 36-43, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35550709
11.
Evolution and Transformation of Uterine Transplantation: A Systematic Review of Surgical Techniques and Outcomes.
J Reconstr Microsurg
; 38(6): 429-440, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34535036
12.
Analysis of serum HE4 levels in various histologic subtypes of epithelial ovarian cancer and other malignant tumors.
Tumour Biol
; 43(1): 355-365, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34957977
13.
Multiple biomarker algorithms to predict epithelial ovarian cancer in women with a pelvic mass: Can additional makers improve performance?
Gynecol Oncol
; 154(1): 150-155, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30992143
14.
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summary.
Future Oncol
; : 1-14, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38501262
15.
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study.
Am J Obstet Gynecol
; 219(5): 459.e1-459.e11, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096321
16.
Assessment of serum HE4 levels throughout the normal menstrual cycle.
Am J Obstet Gynecol
; 217(1): 53.e1-53.e9, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28237871
17.
Predictors for lymph nodes involvement in low risk endometrial cancer.
J Obstet Gynaecol
; 37(4): 514-518, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28339318
18.
Assessing the risk of ovarian malignancy algorithm for the conservative management of women with a pelvic mass.
Gynecol Oncol
; 139(2): 248-52, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26364809
19.
Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial.
Gynecol Oncol
; 139(1): 70-6, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341710
20.
Templated polymers enable selective capture and release of lysophosphatidic acid in human plasma via optimization of non-covalent binding to functional monomers.
Analyst
; 140(22): 7572-7, 2015 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26455441